Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 25 , ISSUE 2 ( February, 2021 ) > List of Articles


Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: Is Sequela the Bigger Threat?

Nitin Rai, Dalim Kumar Baidya

Keywords : COVID-19, ICU mortality, Risk factor

Citation Information : Rai N, Baidya DK. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: Is Sequela the Bigger Threat?. Indian J Crit Care Med 2021; 25 (2):245-246.

DOI: 10.5005/jp-journals-10071-23734

License: CC BY-NC 4.0

Published Online: 22-02-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


PDF Share
  1. Carfì A, Bernabei R, Landi F, for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA 2020;324(6):603–605. DOI: 10.1001/jama.2020.12603.
  2. Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J 2020;55(6):2001217. DOI: 10.1183/13993003.01217-2020.
  3. Wang J, Wang BJ, Yang JC, et al. Advances in the research of mechanism of pulmonary fibrosis induced by corona virus disease 2019 and the corresponding therapeutic measures. Zhonghua Shao Shang Za Zhi 2020;36(8):e006. DOI: 10.3760/cma.j.cn501120-20200307-00132.
  4. Fernández Fabrellas E, Peris Sánchez R, Sabater Abad C, Juan Samper G. Prognosis and follow-up of idiopathic pulmonary fibrosis. Med Sci (Basel) 2018;6(2):51. DOI: 10.3390/medsci6020051.
  5. Kobayashi T, Tanaka K, Fujita T, et al. Bidirectional role of IL-6 signal in pathogenesis of lung fibrosis. Respir Res 2015;16:99. DOI: 10.1186/s12931-015-0261-z.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.